Filing Flows › Boston Scientific (BSX) › Operating margin
Boston Scientific (BSX) operating margin by quarter
Boston Scientific's operating margin was 16.1% in Q3 2026 (third quarter 2026), -5.5 pts from Q2 2026. Over the last 7 quarters it ranged from 15.6% (Q4 2025) to 21.6% (Q2 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 16.1% | -5.5 pts | -4.6 pts |
| Q2 2026 | 21.6% | +0.5 pts | +5.5 pts |
| Q1 2026 | 21.2% | +5.6 pts | +1.4 pts |
| Q4 2025 | 15.6% | -5.1 pts | — |
| Q3 2025 | 20.7% | +4.5 pts | — |
| Q2 2025 | 16.2% | -3.6 pts | — |
| Q1 2025 | 19.8% | — | — |
Q3 2026 at a glance
Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is Boston Scientific's operating margin?
Boston Scientific's operating margin was 16.1% in Q3 2026 (third quarter 2026), -5.5 pts from Q2 2026.
How has Boston Scientific's operating margin changed?
Over the last 7 quarters it ranged from 15.6% (Q4 2025) to 21.6% (Q2 2026).